Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-26

FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Actonel (risedronate sodium) submitted by Allergan, expanding its labeling for additional osteoporosis-related i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actonel (risedronate)

Snippet

SUPPL AP for ACTONEL (RISEDRONATE SODIUM)